Username

Password

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Stephan Stilgenbauer

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Disorders

Procedures

Anatomy

Chemicals & Drugs

Physiology

Living Beings

Ophiostoma

Concepts & Ideas

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Zenz Thorsten; Benner Axel; Dührsen Ulrich; Dürig Jan; Döhner Hartmut; Siffert Winfried; Stilgenbauer Stephan; Nückel Holger
BCL2-938C>A polymorphism and disease progression in chronic lymphocytic leukemia.
Farfsing A; Engel F; Seiffert M; Hartmann E; Ott G; Rosenwald A; Stilgenbauer S; Döhner H; Boutros M; Lichter P; Pscherer A
Gene knockdown studies revealed CCDC50 as a candidate gene in mantle cell lymphoma and chronic lymphocytic leukemia.
Böttcher S; Stilgenbauer S; Busch R; Brüggemann M; Raff T; Pott C; Fischer K; Fingerle-Rowson G; Döhner H; Hallek M; Kneba M; Ritgen M
Standardized MRD flow and ASO IGH RQ-PCR for MRD quantification in CLL patients after rituximab-containing immunochemotherapy: a comparative analysis.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Stephan Stilgenbauer (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Zenz Thorsten; Benner Axel; Dührsen Ulrich; Dürig Jan; Döhner Hartmut; Siffert Winfried; Stilgenbauer Stephan; Nückel Holger
BCL2-938C>A polymorphism and disease progression in chronic lymphocytic leukemia.
Leukemia & lymphoma 2009;50(11):1837-42.
2009: Farfsing A; Engel F; Seiffert M; Hartmann E; Ott G; Rosenwald A; Stilgenbauer S; Döhner H; Boutros M; Lichter P; Pscherer A
Gene knockdown studies revealed CCDC50 as a candidate gene in mantle cell lymphoma and chronic lymphocytic leukemia.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2009;23(11):2018-26.
2009: Böttcher S; Stilgenbauer S; Busch R; Brüggemann M; Raff T; Pott C; Fischer K; Fingerle-Rowson G; Döhner H; Hallek M; Kneba M; Ritgen M
Standardized MRD flow and ASO IGH RQ-PCR for MRD quantification in CLL patients after rituximab-containing immunochemotherapy: a comparative analysis.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2009;23(11):2007-17.
2009: Seiler Till; Woelfle Manuela; Yancopoulos Sophia; Catera Rosa; Li Wentian; Hatzi Katerina; Moreno Carol; Torres Marcela; Paul Santanu; Dohner Hartmut; Stilgenbauer Stephan; Kaufman Matthew S; Kolitz Jonathan E; Allen Steven L; Rai Kanti R; Chu Charles C; Chiorazzi Nicholas
Characterization of structurally defined epitopes recognized by monoclonal antibodies produced by chronic lymphocytic leukemia B cells.
Blood 2009;114(17):3615-24.
2009: Eichhorst Barbara F; Busch Raymonde; Stilgenbauer Stephan; Stauch Martina; Bergmann Manuela A; Ritgen Matthias; Kranzhöfer Nicole; Rohrberg Robert; Söling Ulrike; Burkhard Oswald; Westermann Anne; Goede Valentin; Schweighofer Carmen D; Fischer Kirsten; Fink Anna-Maria; Wendtner Clemens M; Brittinger Günter; Döhner Hartmut; Emmerich Bertold; Hallek Michael;
First-line therapy with fludarabine compared with chlorambucil does not result in a major benefit for elderly patients with advanced chronic lymphocytic leukemia.
Blood 2009;114(16):3382-91.
2009: Giannopoulos K; Dmoszynska A; Kowal M; Wasik-Szczepanek E; Bojarska-Junak A; Rolinski J; Döhner H; Stilgenbauer S; Bullinger L
Thalidomide exerts distinct molecular antileukemic effects and combined thalidomide/fludarabine therapy is clinically effective in high-risk chronic lymphocytic leukemia.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2009;23(10):1771-8.
2009: Zenz Thorsten; Häbe Sonja; Denzel Tina; Mohr Julia; Winkler Dirk; Bühler Andreas; Sarno Antonio; Groner Silja; Mertens Daniel; Busch Raymonde; Hallek Michael; Döhner Hartmut; Stilgenbauer Stephan
Detailed analysis of p53 pathway defects in fludarabine-refractory chronic lymphocytic leukemia (CLL): dissecting the contribution of 17p deletion, TP53 mutation, p53-p21 dysfunction, and miR34a in a prospective clinical trial.
Blood 2009;114(13):2589-97.
2009: Stilgenbauer Stephan; Zenz Thorsten; Winkler Dirk; Bühler Andreas; Schlenk Richard F; Groner Silja; Busch Raymonde; Hensel Manfred; Dührsen Ulrich; Finke Jürgen; Dreger Peter; Jäger Ulrich; Lengfelder Eva; Hohloch Karin; Söling Ulrike; Schlag Rudolf; Kneba Michael; Hallek Michael; Döhner Hartmut;
Subcutaneous alemtuzumab in fludarabine-refractory chronic lymphocytic leukemia: clinical results and prognostic marker analyses from the CLL2H study of the German Chronic Lymphocytic Leukemia Study Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(24):3994-4001.
2009: Geisler Christian; Jurlander Jesper; Bullinger Lars; Sander Sandrine; Brown Peter; Benner Axel; Philip Preben; Döhner Hartmut; Stilgenbauer Stephan;
Danish CLL2-Study revisited: FISH on a cohort with a 20-yr follow-up confirms the validity of the hierarchical model of genomic aberrations in chronic lymphocytic leukaemia.
European journal of haematology 2009;83(2):156-8.
2009: Porpaczy E; Bilban M; Heinze G; Gruber M; Vanura K; Schwarzinger I; Stilgenbauer S; Streubel B; Fonatsch C; Jaeger U
Gene expression signature of chronic lymphocytic leukaemia with Trisomy 12.
European journal of clinical investigation 2009;39(7):568-75.
2009: Steininger C; Rassenti L Z; Vanura K; Eigenberger K; Jäger U; Kipps T J; Mannhalter C; Stilgenbauer S; Popow-Kraupp T
Relative seroprevalence of human herpes viruses in patients with chronic lymphocytic leukaemia.
European journal of clinical investigation 2009;39(6):497-506.
2009: Zenz Thorsten; Mohr Julia; Eldering Eric; Kater Arnon P; Bühler Andreas; Kienle Dirk; Winkler Dirk; Dürig Jan; van Oers Marinus H J; Mertens Daniel; Döhner Hartmut; Stilgenbauer Stephan
miR-34a as part of the resistance network in chronic lymphocytic leukemia.
Blood 2009;113(16):3801-8.
2009: Zenz Thorsten; Mohr Julia; Edelmann Jennifer; Sarno Antonio; Hoth Patrick; Heuberger Maria; Helfrich Hanne; Mertens Daniel; Dohner Hartmut; Stilgenbauer Stephan
Treatment resistance in chronic lymphocytic leukemia: the role of the p53 pathway.
Leukemia & lymphoma 2009;50(3):510-3.
2009: Mertens Daniel; Philippen Angela; Ruppel Melanie; Allegra Danilo; Bhattacharya Nupur; Tschuch Cordula; Wolf Stephan; Idler Irina; Zenz Thorsten; Stilgenbauer Stephan
Chronic lymphocytic leukemia and 13q14: miRs and more.
Leukemia & lymphoma 2009;50(3):502-5.
2009: Bommer Martin; Hütter Marie-Luise; Stilgenbauer Stephan; de Hoog G Sybren; de Beer Z Wilhelm; Wellinghausen Nele
Fatal Ophiostoma piceae infection in a patient with acute lymphoblastic leukaemia.
Journal of medical microbiology 2009;58(Pt 3):381-5.
2009: Giannopoulos K; Mertens D; Bühler A; Barth T F E; Idler I; Möller P; Kröber A; Greiner J; Chocholska S; Dmoszyñska A; Roliñski J; Döhner H; Stilgenbauer S; Schmitt M
The candidate immunotherapeutical target, the receptor for hyaluronic acid-mediated motility, is associated with proliferation and shows prognostic value in B-cell chronic lymphocytic leukemia.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2009;23(3):519-27.
2008: Zenz Thorsten; Benner Axel; Döhner Hartmut; Stilgenbauer Stephan
Chronic lymphocytic leukemia and treatment resistance in cancer: the role of the p53 pathway.
Cell cycle (Georgetown, Tex.) 2008;7(24):3810-4.
2008: Vanura Katrina; Le Trang; Esterbauer Harald; Späth Florentin; Porpaczy Edit; Shehata Medhat; Eigenberger Karin; Hauswirth Alexander; Skrabs Cathrin; Krömer Elisabeth; Schwarzinger Ilse; Streubel Berthold; Steininger Christoph; Fonatsch Christa; Stilgenbauer Stephan; Wagner Oswald; Gaiger Alexander; Jäger Ulrich
Autoimmune conditions and chronic infections in chronic lymphocytic leukemia patients at diagnosis are associated with unmutated IgVH genes.
Haematologica 2008;93(12):1912-6.
2008: Buck Andreas K; Bommer Martin; Juweid Malik E; Glatting Gerhard; Stilgenbauer Stephan; Mottaghy Felix M; Schulz Melanie; Kull Thomas; Bunjes Donald; Möller Peter; Döhner Hartmut; Reske Sven N
First demonstration of leukemia imaging with the proliferation marker 18F-fluorodeoxythymidine.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2008;49(11):1756-62.
2008: Sander Sandrine; Bullinger Lars; Klapproth Kay; Fiedler Katja; Kestler Hans A; Barth Thomas F E; Möller Peter; Stilgenbauer Stephan; Pollack Jonathan R; Wirth Thomas
MYC stimulates EZH2 expression by repression of its negative regulator miR-26a.
Blood 2008;112(10):4202-12.
2008: Schetelig Johannes; van Biezen Anja; Brand Ronald; Caballero Dolores; Martino Rodrigo; Itala Maija; García-Marco José A; Volin Liisa; Schmitz Norbert; Schwerdtfeger Rainer; Ganser Arnold; Onida Francesco; Mohr Brigitte; Stilgenbauer Stephan; Bornhäuser Martin; de Witte Theo; Dreger Peter
Allogeneic hematopoietic stem-cell transplantation for chronic lymphocytic leukemia with 17p deletion: a retrospective European Group for Blood and Marrow Transplantation analysis.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(31):5094-100.
2008: Zenz Thorsten; Kröber Alexander; Scherer Katrin; Häbe Sonja; Bühler Andreas; Benner Axel; Denzel Tina; Winkler Dirk; Edelmann Jennifer; Schwänen Carsten; Döhner Hartmut; Stilgenbauer Stephan
Monoallelic TP53 inactivation is associated with poor prognosis in chronic lymphocytic leukemia: results from a detailed genetic characterization with long-term follow-up.
Blood 2008;112(8):3322-9.
2008: Katzenberger Tiemo; Kienle Dirk; Stilgenbauer Stephan; Höller Sylvia; Schilling Carolin; Mäder Uwe; Puppe Bernhard; Petzoldt Celine; Sander Sandrine; Bullinger Lars; Stöcklein Heike; Kalla Jörg; Hartmann Elena; Adam Patrick; Ott M Michaela; Müller-Hermelink Hans-Konrad; Rosenwald Andreas; Ott German
Delineation of distinct tumour profiles in mantle cell lymphoma by detailed cytogenetic, interphase genetic and morphological analysis.
British journal of haematology 2008;142(4):538-50.
2008: Zenz Thorsten; Häbe Sonja; Benner Axel; Kienle Dirk; Döhner Hartmut; Stilgenbauer Stephan
The MDM2 -309 T/G promoter single nucleotide polymorphism does not alter disease characteristics in chronic lymphocytic leukemia.
Haematologica 2008;93(7):1111-3.
2008: Zenz Thorsten; Mertens Daniel; Döhner Hartmut; Stilgenbauer Stephan
Molecular diagnostics in chronic lymphocytic leukemia - pathogenetic and clinical implications.
Leukemia & lymphoma 2008;49(5):864-73.
2008: Sander Sandrine; Bullinger Lars; Leupolt Elke; Benner Axel; Kienle Dirk; Katzenberger Tiemo; Kalla Jörg; Ott German; Müller-Hermelink Hans Konrad; Barth Thomas F E; Möller Peter; Lichter Peter; Döhner Hartmut; Stilgenbauer Stephan
Genomic aberrations in mantle cell lymphoma detected by interphase fluorescence in situ hybridization. Incidence and clinicopathological correlations.
Haematologica 2008;93(5):680-7.
2008: Roos Göran; Kröber Alexander; Grabowski Pawel; Kienle Dirk; Bühler Andreas; Döhner Hartmut; Rosenquist Richard; Stilgenbauer Stephan
Short telomeres are associated with genetic complexity, high-risk genomic aberrations, and short survival in chronic lymphocytic leukemia.
Blood 2008;111(4):2246-52.
2008: Stilgenbauer Stephan
Advances in the use of alemtuzumab in CLL.
Clinical advances in hematology & oncology : H&O 2008;6(1):23-4.
2007: Kainz Birgit; Shehata Medhat; Bilban Martin; Kienle Dirk; Heintel Daniel; Krömer-Holzinger Elisabeth; Le Trang; Kröber Alexander; Heller Gerwin; Schwarzinger Ilse; Demirtas Dita; Chott Andreas; Döhner Hartmut; Zöchbauer-Müller Sabine; Fonatsch Christa; Zielinski Christoph; Stilgenbauer Stephan; Gaiger Alexander; Wagner Oswald; Jäger Ulrich
Overexpression of the paternally expressed gene 10 (PEG10) from the imprinted locus on chromosome 7q21 in high-risk B-cell chronic lymphocytic leukemia.
International journal of cancer. Journal international du cancer 2007;121(9):1984-93.
2007: Zenz Thorsten; Döhner Hartmut; Stilgenbauer Stephan
Genetics and risk-stratified approach to therapy in chronic lymphocytic leukemia.
Best practice & research. Clinical haematology 2007;20(3):439-53.
2007: Stilgenbauer Stephan; Sander Sandrine; Bullinger Lars; Benner Axel; Leupolt Elke; Winkler Dirk; Kröber Alexander; Kienle Dirk; Lichter Peter; Döhner Hartmut
Clonal evolution in chronic lymphocytic leukemia: acquisition of high-risk genomic aberrations associated with unmutated VH, resistance to therapy, and short survival.
Haematologica 2007;92(9):1242-5.
2007: Seiffert M; Stilgenbauer S; Döhner H; Lichter P
Efficient nucleofection of primary human B cells and B-CLL cells induces apoptosis, which depends on the microenvironment and on the structure of transfected nucleic acids.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2007;21(9):1977-83.
2007: Hensel Manfred; Zoz Martin; Giesecke Christian; Benner Axel; Neben Kai; Jauch Anna; Stilgenbauer Stephan; Ho Anthony D; Krämer Alwin
High rate of centrosome aberrations and correlation with proliferative activity in patients with untreated B-cell chronic lymphocytic leukemia.
International journal of cancer. Journal international du cancer 2007;121(5):978-83.
2007: Kienle Dirk; Katzenberger Tiemo; Ott German; Saupe Doreen; Benner Axel; Kohlhammer Holger; Barth Thomas F E; Höller Sylvia; Kalla Jörg; Rosenwald Andreas; Müller-Hermelink Hans Konrad; Möller Peter; Lichter Peter; Döhner Hartmut; Stilgenbauer Stephan
Quantitative gene expression deregulation in mantle-cell lymphoma: correlation with clinical and biologic factors.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(19):2770-7.
2007: Kalla Claudia; Scheuermann Markus O; Kube Ina; Schlotter Magdalena; Mertens Daniel; Döhner Hartmut; Stilgenbauer Stephan; Lichter Peter
Analysis of 11q22-q23 deletion target genes in B-cell chronic lymphocytic leukaemia: evidence for a pathogenic role of NPAT, CUL5, and PPP2R1B.
European journal of cancer (Oxford, England : 1990) 2007;43(8):1328-35.
2007: Haferlach Claudia; Rieder Harald; Lillington Debra M; Dastugue Nicole; Hagemeijer Anne; Harbott Jochen; Stilgenbauer Stephan; Knuutila Sakari; Johansson Bertil; Fonatsch Christa
Proposals for standardized protocols for cytogenetic analyses of acute leukemias, chronic lymphocytic leukemia, chronic myeloid leukemia, chronic myeloproliferative disorders, and myelodysplastic syndromes.
Genes, chromosomes & cancer 2007;46(5):494-9.
2007: Ringhoffer Mark; Harsdorf Stephanie von; Schmitt Michael; Wiesneth Markus; Zenz Thorsten; Stilgenbauer Stephan; Greiner Jochen; Döhner Konstanze; Marx Martin; Döhner Hartmut; Bunjes Donald
Reduced-intensity conditioning followed by T-cell depleted allogeneic stem cell transplantation for patients with chronic myeloid leukaemia and minimal residual disease at the time of transplant: high risk of molecular relapse.
British journal of haematology 2007;136(1):127-30.
2006: Buck Andreas K; Bommer Martin; Stilgenbauer Stephan; Juweid Malik; Glatting Gerhard; Schirrmeister Holger; Mattfeldt Torsten; Tepsic Djurdja; Bunjes Donald; Mottaghy Felix M; Krause Bernd J; Neumaier Bernd; Döhner Hartmut; Möller Peter; Reske Sven N
Molecular imaging of proliferation in malignant lymphoma.
Cancer research 2006;66(22):11055-61.
2006: Winkler Dirk; Döhner Hartmut; Stilgenbauer Stephan
Genetics, gene expression, and targeted therapies in chronic lymphocytic leukemia.
Current drug targets 2006;7(10):1313-27.
2006: Zenz Thorsten; Ritgen Matthias; Dreger Peter; Kröber Alexander; Barth Thomas F; Schlenk Richard; Böttcher Sebastian; Hallek Michael J; Kneba Michael; Bunjes Donald; Döhner Hartmut; Stilgenbauer Stephan
Autologous graft-versus-host disease-like syndrome after an alemtuzumab-containing conditioning regimen and autologous stem cell transplantation for chronic lymphocytic leukemia.
Blood 2006;108(6):2127-30.
2006: Pscherer Armin; Schliwka Julia; Wildenberger Kathrin; Mincheva Antoaneta; Schwaenen Carsten; Döhner Hartmut; Stilgenbauer Stephan; Lichter Peter
Antagonizing inactivated tumor suppressor genes and activated oncogenes by a versatile transgenesis system: application in mantle cell lymphoma.
The FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2006;20(8):1188-90.
2006: Bilban M; Heintel D; Scharl T; Woelfel T; Auer M M; Porpaczy E; Kainz B; Kröber A; Carey V J; Shehata M; Zielinski C; Pickl W; Stilgenbauer S; Gaiger A; Wagner O; Jäger U;
Deregulated expression of fat and muscle genes in B-cell chronic lymphocytic leukemia with high lipoprotein lipase expression.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2006;20(6):1080-8.
2006: Mertens Daniel; Wolf Stephan; Tschuch Cordula; Mund Cora; Kienle Dirk; Ohl Sibylle; Schroeter Petra; Lyko Frank; Döhner Hartmut; Stilgenbauer Stephan; Lichter Peter
Allelic silencing at the tumor-suppressor locus 13q14.3 suggests an epigenetic tumor-suppressor mechanism.
Proceedings of the National Academy of Sciences of the United States of America 2006;103(20):7741-6.
2006: Seiler Till; Döhner Hartmut; Stilgenbauer Stephan
Risk stratification in chronic lymphocytic leukemia.
Seminars in oncology 2006;33(2):186-94.
2006: Thorsélius Mia; Kröber Alexander; Murray Fiona; Thunberg Ulf; Tobin Gerard; Bühler Andreas; Kienle Dirk; Albesiano Emilia; Maffei Rossana; Dao-Ung Lan-Phuong; Wiley James; Vilpo Juhani; Laurell Anna; Merup Mats; Roos Göran; Karlsson Karin; Chiorazzi Nicholas; Marasca Roberto; Döhner Hartmut; Stilgenbauer Stephan; Rosenquist Richard
Strikingly homologous immunoglobulin gene rearrangements and poor outcome in VH3-21-using chronic lymphocytic leukemia patients independent of geographic origin and mutational status.
Blood 2006;107(7):2889-94.
2006: Wolf Stephan; Mertens Daniel; Pscherer Armin; Schroeter Petra; Winkler Dirk; Gröne Hermann-Josef; Hofele Christof; Hemminki Kari; Kumar Rajiv; Steineck Gunnar; Döhner Hartmut; Stilgenbauer Stephan; Lichter Peter
Ala228 variant of trail receptor 1 affecting the ligand binding site is associated with chronic lymphocytic leukemia, mantle cell lymphoma, prostate cancer, head and neck squamous cell carcinoma and bladder cancer.
International journal of cancer. Journal international du cancer 2006;118(7):1831-5.
2006: Kienle Dirk; Benner Axel; Kröber Alexander; Winkler Dirk; Mertens Daniel; Bühler Andreas; Seiler Till; Jäger Ulrich; Lichter Peter; Döhner Hartmut; Stilgenbauer Stephan
Distinct gene expression patterns in chronic lymphocytic leukemia defined by usage of specific VH genes.
Blood 2006;107(5):2090-3.
2006: Zenz Thorsten; Schlenk Richard F; Glatting Gerhard; Neumaier Bernd; Blumstein Norbert; Buchmann Inga; von Harsdorf Stephanie; Ringhoffer Mark; Wiesneth Markus; Keller Frieder; Kotzerke Jörg; Röttinger Erwin; Stilgenbauer Stephan; Döhner Hartmut; Reske Sven N; Bunjes Donald
Bone marrow transplantation nephropathy after an intensified conditioning regimen with radioimmunotherapy and allogeneic stem cell transplantation.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2006;47(2):278-86.
2006: Kröber Alexander; Bloehdorn Johannes; Hafner Sebastian; Bühler Andreas; Seiler Till; Kienle Dirk; Winkler Dirk; Bangerter Markus; Schlenk Richard F; Benner Axel; Lichter Peter; Döhner Hartmut; Stilgenbauer Stephan
Additional genetic high-risk features such as 11q deletion, 17p deletion, and V3-21 usage characterize discordance of ZAP-70 and VH mutation status in chronic lymphocytic leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(6):969-75.
2006: Eichhorst Barbara F; Busch Raymonde; Hopfinger Georg; Pasold Rita; Hensel Manfred; Steinbrecher Cordelia; Siehl Siegfried; Jäger Ulrich; Bergmann Manuela; Stilgenbauer Stephan; Schweighofer Carmen; Wendtner Clemens M; Döhner Hartmut; Brittinger Günter; Emmerich Bertold; Hallek Michael;
Fludarabine plus cyclophosphamide versus fludarabine alone in first-line therapy of younger patients with chronic lymphocytic leukemia.
Blood 2006;107(3):885-91.
2006: Skogsberg S; Tobin G; Kröber A; Kienle D; Thunberg U; Aleskog A; Karlsson K; Laurell A; Merup M; Vilpo J; Sundström C; Roos G; Jernberg-Wiklund H; Döhner H; Nilsson K; Stilgenbauer S; Rosenquist R
The G(-248)A polymorphism in the promoter region of the Bax gene does not correlate with prognostic markers or overall survival in chronic lymphocytic leukemia.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2006;20(1):77-81.
2005: Ringhoffer Mark; Blumstein Norbert; Neumaier Bernd; Glatting Gerhard; von Harsdorf Stephanie; Buchmann Inga; Wiesneth Markus; Kotzerke Jörg; Zenz Thorsten; Buck Andreas K; Schauwecker Peter; Stilgenbauer Stephan; Döhner Hartmut; Reske Sven N; Bunjes Donald
188Re or 90Y-labelled anti-CD66 antibody as part of a dose-reduced conditioning regimen for patients with acute leukaemia or myelodysplastic syndrome over the age of 55: results of a phase I-II study.
British journal of haematology 2005;130(4):604-13.
2005: Stilgenbauer Stephan
ZAP-70 methylation and expression status in chronic lymphocytic leukemia.
Haematologica 2005;90(8):1012.
2005: Winkler D; Schneider C; Kröber A; Pasqualucci L; Lichter P; Döhner H; Stilgenbauer S
Protein expression analysis of chromosome 12 candidate genes in chronic lymphocytic leukemia (CLL).
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2005;19(7):1211-5.
2005: Heintel D; Kienle D; Shehata M; Kröber A; Kroemer E; Schwarzinger I; Mitteregger D; Le T; Gleiss A; Mannhalter C; Chott A; Schwarzmeier J; Fonatsch C; Gaiger A; Döhner H; Stilgenbauer S; Jäger U;
High expression of lipoprotein lipase in poor risk B-cell chronic lymphocytic leukemia.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2005;19(7):1216-23.
2005: Kienle Dirk L; Korz Christian; Hosch Beate; Benner Axel; Mertens Daniel; Habermann Annett; Kröber Alexander; Jäger Ulrich; Lichter Peter; Döhner Hartmut; Stilgenbauer Stephan
Evidence for distinct pathomechanisms in genetic subgroups of chronic lymphocytic leukemia revealed by quantitative expression analysis of cell cycle, activation, and apoptosis-associated genes.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(16):3780-92.
2005: Kalla Claudia; Nentwich Hagen; Schlotter Magdalena; Mertens Daniel; Wildenberger Kathrin; Döhner Hartmut; Stilgenbauer Stephan; Lichter Peter
Translocation t(X;11)(q13;q23) in B-cell chronic lymphocytic leukemia disrupts two novel genes.
Genes, chromosomes & cancer 2005;42(2):128-43.
2005: Liebisch Peter; Scheck Daniel; Erné Seiichi Alvise; Wellmann Alexander; Wendl Christiane; Janczik Sibylle; Kolmus Sonja; Kröber Alexander; Einsele Hermann; Straka Christian; Goldschmidt Hartmut; Benner Axel; Stilgenbauer Stephan; Döhner Hartmut
Duplication of chromosome arms 9q and 11q: evidence for a novel, 14q32 translocation-independent pathogenetic pathway in multiple myeloma.
Genes, chromosomes & cancer 2005;42(1):78-81.
2005: Stilgenbauer S; Döhner H
Genotypic prognostic markers.
Current topics in microbiology and immunology 2005;294():147-64.
2004: Haslinger Christian; Schweifer Norbert; Stilgenbauer Stephan; Döhner Hartmut; Lichter Peter; Kraut Norbert; Stratowa Christian; Abseher Roger
Microarray gene expression profiling of B-cell chronic lymphocytic leukemia subgroups defined by genomic aberrations and VH mutation status.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(19):3937-49.
2004: Böttcher S; Ritgen M; Pott C; Brüggemann M; Raff T; Stilgenbauer S; Döhner H; Dreger P; Kneba M
Comparative analysis of minimal residual disease detection using four-color flow cytometry, consensus IgH-PCR, and quantitative IgH PCR in CLL after allogeneic and autologous stem cell transplantation.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2004;18(10):1637-45.
2004: Ritgen Matthias; Stilgenbauer Stephan; von Neuhoff Nils; Humpe Andreas; Brüggemann Monika; Pott Christiane; Raff Thorsten; Kröber Alexander; Bunjes Donald; Schlenk Richard; Schmitz Norbert; Döhner Hartmut; Kneba Michael; Dreger Peter
Graft-versus-leukemia activity may overcome therapeutic resistance of chronic lymphocytic leukemia with unmutated immunoglobulin variable heavy-chain gene status: implications of minimal residual disease measurement with quantitative PCR.
Blood 2004;104(8):2600-2.
2004: Stilgenbauer Stephan; Döhner Hartmut
Molecular genetics and its clinical relevance.
Hematology/oncology clinics of North America 2004;18(4):827-48, viii.
2004: Kohlhammer Holger; Schwaenen Carsten; Wessendorf Swen; Holzmann Karlheinz; Kestler Hans A; Kienle Dirk; Barth Thomas F E; Möller Peter; Ott German; Kalla Jörg; Radlwimmer Bernhard; Pscherer Armin; Stilgenbauer Stephan; Döhner Hartmut; Lichter Peter; Bentz Martin
Genomic DNA-chip hybridization in t(11;14)-positive mantle cell lymphomas shows a high frequency of aberrations and allows a refined characterization of consensus regions.
Blood 2004;104(3):795-801.
2004: Lyko Frank; Stach Dirk; Brenner Axel; Stilgenbauer Stephan; Döhner Hartmut; Wirtz Michaela; Wiessler Manfred; Schmitz Oliver J
Quantitative analysis of DNA methylation in chronic lymphocytic leukemia patients.
Electrophoresis 2004;25(10-11):1530-5.
2004: Wendtner C-M; Ritgen M; Schweighofer C D; Fingerle-Rowson G; Campe H; Jäger G; Eichhorst B; Busch R; Diem H; Engert A; Stilgenbauer S; Döhner H; Kneba M; Emmerich B; Hallek M;
Consolidation with alemtuzumab in patients with chronic lymphocytic leukemia (CLL) in first remission--experience on safety and efficacy within a randomized multicenter phase III trial of the German CLL Study Group (GCLLSG).
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2004;18(6):1093-101.
2004: Heintel D; Kroemer E; Kienle D; Schwarzinger I; Gleiss A; Schwarzmeier J; Marculescu R; Le T; Mannhalter C; Gaiger A; Stilgenbauer S; Döhner H; Fonatsch C; Jäger U;
High expression of activation-induced cytidine deaminase (AID) mRNA is associated with unmutated IGVH gene status and unfavourable cytogenetic aberrations in patients with chronic lymphocytic leukaemia.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2004;18(4):756-62.
2004: Dreger Peter; Stilgenbauer Stephan; Benner Axel; Ritgen Matthias; Kröber Alexander; Kneba Michael; Schmitz Norbert; Döhner Hartmut
The prognostic impact of autologous stem cell transplantation in patients with chronic lymphocytic leukemia: a risk-matched analysis based on the VH gene mutational status.
Blood 2004;103(7):2850-8.
2004: Schwaenen Carsten; Nessling Michelle; Wessendorf Swen; Salvi Tatjana; Wrobel Gunnar; Radlwimmer Bernhard; Kestler Hans A; Haslinger Christian; Stilgenbauer Stephan; Döhner Hartmut; Bentz Martin; Lichter Peter
Automated array-based genomic profiling in chronic lymphocytic leukemia: development of a clinical tool and discovery of recurrent genomic alterations.
Proceedings of the National Academy of Sciences of the United States of America 2004;101(4):1039-44.
2004: Byrd John C; Stilgenbauer Stephan; Flinn Ian W
Chronic lymphocytic leukemia.
Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program 2004;():163-83.
2003: Liebisch P; Wendl C; Wellmann A; Kröber A; Schilling G; Goldschmidt H; Einsele H; Straka C; Bentz M; Stilgenbauer S; Döhner H
High incidence of trisomies 1q, 9q, and 11q in multiple myeloma: results from a comprehensive molecular cytogenetic analysis.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2003;17(12):2535-7.
2003: Kienle Dirk; Kröber Alexander; Katzenberger Tiemo; Ott German; Leupolt Elke; Barth Thomas F E; Möller Peter; Benner Axel; Habermann Annett; Müller-Hermelink Hans Konrad; Bentz Martin; Lichter Peter; Dohner Hartmut; Stilgenbauer Stephan
VH mutation status and VDJ rearrangement structure in mantle cell lymphoma: correlation with genomic aberrations, clinical characteristics, and outcome.
Blood 2003;102(8):3003-9.
2003: Liebisch Peter; Viardot Andreas; Bassermann Nicole; Wendl Christiane; Roth Katrin; Goldschmidt Hartmut; Einsele Hermann; Straka Christian; Stilgenbauer Stephan; Döhner Hartmut; Bentz Martin
Value of comparative genomic hybridization and fluorescence in situ hybridization for molecular diagnostics in multiple myeloma.
British journal of haematology 2003;122(2):193-201.
2003: Ritgen Matthias; Lange Alexandra; Stilgenbauer Stephan; Dohner Hartmut; Bretscher Christian; Bosse Heidi; Stuhr Ariane; Kneba Michael; Dreger Peter
Unmutated immunoglobulin variable heavy-chain gene status remains an adverse prognostic factor after autologous stem cell transplantation for chronic lymphocytic leukemia.
Blood 2003;101(5):2049-53.
2003: Stach Dirk; Schmitz Oliver J; Stilgenbauer Stephan; Benner Axel; Döhner Hartmut; Wiessler Manfred; Lyko Frank
Capillary electrophoretic analysis of genomic DNA methylation levels.
Nucleic acids research 2003;31(2):E2.
2003: Katzenberger Tiemo; Lohr Andreas; Schwarz Stephan; Dreyling Martin; Schoof Julia; Nickenig Christina; Stilgenbauer Stephan; Kalla Jörg; Ott M Michaela; Müller-Hermelink Hans Konrad; Ott German
Genetic analysis of de novo CD5+ diffuse large B-cell lymphomas suggests an origin from a somatically mutated CD5+ progenitor B cell.
Blood 2003;101(2):699-702.
2002: Beà Sílvia; López-Guillermo Armando; Ribas Maria; Puig Xavier; Pinyol Magda; Carrió Ana; Zamora Lurdes; Soler Francesc; Bosch Francesc; Stilgenbauer Stephan; Colomer Dolors; Miró Rosa; Montserrat Emili; Campo Elias
Genetic imbalances in progressed B-cell chronic lymphocytic leukemia and transformed large-cell lymphoma (Richter's syndrome).
The American journal of pathology 2002;161(3):957-68.
2002: Stilgenbauer Stephan; Döhner Hartmut
Campath-1H-induced complete remission of chronic lymphocytic leukemia despite p53 gene mutation and resistance to chemotherapy.
The New England journal of medicine 2002;347(6):452-3.
2002: Kröber Alexander; Seiler Till; Benner Axel; Bullinger Lars; Brückle Elsbeth; Lichter Peter; Döhner Hartmut; Stilgenbauer Stephan
V(H) mutation status, CD38 expression level, genomic aberrations, and survival in chronic lymphocytic leukemia.
Blood 2002;100(4):1410-6.
2002: Barth Thomas F E; Bentz Martin; Leithäuser Frank; Stilgenbauer Stephan; Siebert Reiner; Schlotter Magdalena; Schlenk Richard F; Döhner Hartmut; Möller Peter
Pathogenic complexity of gastric B-cell lymphoma.
Blood 2002;100(3):1095-6; author reply 1096-7.
2002: Stilgenbauer S; Bullinger L; Lichter P; Döhner H;
Genetics of chronic lymphocytic leukemia: genomic aberrations and V(H) gene mutation status in pathogenesis and clinical course.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2002;16(6):993-1007.
2002: Korz Christian; Pscherer Armin; Benner Axel; Mertens Daniel; Schaffner Claudia; Leupolt Elke; Döhner Hartmut; Stilgenbauer Stephan; Lichter Peter
Evidence for distinct pathomechanisms in B-cell chronic lymphocytic leukemia and mantle cell lymphoma by quantitative expression analysis of cell cycle and apoptosis-associated genes.
Blood 2002;99(12):4554-61.
2002: Mertens Daniel; Wolf Stephan; Schroeter Petra; Schaffner Claudia; Döhner Hartmut; Stilgenbauer Stephan; Lichter Peter
Down-regulation of candidate tumor suppressor genes within chromosome band 13q14.3 is independent of the DNA methylation pattern in B-cell chronic lymphocytic leukemia.
Blood 2002;99(11):4116-21.
2001: Barth T F; Bentz M; Leithäuser F; Stilgenbauer S; Siebert R; Schlotter M; Schlenk R F; Döhner H; Möller P
Molecular-cytogenetic comparison of mucosa-associated marginal zone B-cell lymphoma and large B-cell lymphoma arising in the gastro-intestinal tract.
Genes, chromosomes & cancer 2001;31(4):316-25.
2001: Wolf S; Mertens D; Schaffner C; Korz C; Döhner H; Stilgenbauer S; Lichter P
B-cell neoplasia associated gene with multiple splicing (BCMS): the candidate B-CLL gene on 13q14 comprises more than 560 kb covering all critical regions.
Human molecular genetics 2001;10(12):1275-85.
2001: Stratowa C; Löffler G; Lichter P; Stilgenbauer S; Haberl P; Schweifer N; Döhner H; Wilgenbus K K
CDNA microarray gene expression analysis of B-cell chronic lymphocytic leukemia proposes potential new prognostic markers involved in lymphocyte trafficking.
International journal of cancer. Journal international du cancer 2001;91(4):474-80.
2000: Döhner H; Stilgenbauer S; Benner A; Leupolt E; Kröber A; Bullinger L; Döhner K; Bentz M; Lichter P
Genomic aberrations and survival in chronic lymphocytic leukemia.
The New England journal of medicine 2000;343(26):1910-6.
2000: Mertens D; Wolf S; Bullinger L; Ohl S; Schaffner C; Döhner H; Stilgenbauer S; Lichter P
BCMSUN, a candidate gene for B-cell chronic lymphocytic leukemia and mantle-cell lymphoma, has an independently expressed homolog on 1p22-p31, BCMSUN-like.
International journal of cancer. Journal international du cancer 2000;88(5):692-7.
2000: Kalla J; Stilgenbauer S; Schaffner C; Wolf S; Ott G; Greiner A; Rosenwald A; Döhner H; Müller-Hermelink H K; Lichter P
Heterogeneity of the API2-MALT1 gene rearrangement in MALT-type lymphoma.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2000;14(11):1967-74.
2000: Bullinger L; Leupolt E; Schaffner C; Mertens D; Bentz M; Lichter P; Döhner H; Stilgenbauer S
BCL10 is not the gene inactivated by mutation in the 1p22 deletion region in mantle cell lymphoma.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2000;14(8):1490-2.
2000: Stilgenbauer S; Lichter P; Döhner H
Genetic features of B-cell chronic lymphocytic leukemia.
Reviews in clinical and experimental hematology 2000;4(1):48-72.
2000: Schaffner C; Idler I; Stilgenbauer S; Döhner H; Lichter P
Mantle cell lymphoma is characterized by inactivation of the ATM gene.
Proceedings of the National Academy of Sciences of the United States of America 2000;97(6):2773-8.
2000: Bentz M; Plesch A; Bullinger L; Stilgenbauer S; Ott G; Müller-Hermelink H K; Baudis M; Barth T F; Möller P; Lichter P; Döhner H
t(11;14)-positive mantle cell lymphomas exhibit complex karyotypes and share similarities with B-cell chronic lymphocytic leukemia.
Genes, chromosomes & cancer 2000;27(3):285-94.
2000: Stilgenbauer S; Schaffner C; Winkler D; Ott G; Leupolt E; Bentz M; Möller P; Müller-Hermelink H K; James M R; Lichter P; Döhner H
The ATM gene in the pathogenesis of mantle-cell lymphoma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2000;11 Suppl 1():127-30.
1999: Knörr C; Amrehn C; Seeberger H; Rosenwald A; Stilgenbauer S; Ott G; Müller Hermelink H K; Greiner A
Expression of costimulatory molecules in low-grade mucosa-associated lymphoid tissue-type lymphomas in vivo.
The American journal of pathology 1999;155(6):2019-27.
1999: Rosenwald A; Ott G; Stilgenbauer S; Kalla J; Bredt M; Katzenberger T; Greiner A; Ott M M; Gawin B; Döhner H; Müller-Hermelink H K
Exclusive detection of the t(11;18)(q21;q21) in extranodal marginal zone B cell lymphomas (MZBL) of MALT type in contrast to other MZBL and extranodal large B cell lymphomas.
The American journal of pathology 1999;155(6):1817-21.
1999: Stilgenbauer S; Winkler D; Ott G; Schaffner C; Leupolt E; Bentz M; Möller P; Müller-Hermelink H K; James M R; Lichter P; Döhner H
Molecular characterization of 11q deletions points to a pathogenic role of the ATM gene in mantle cell lymphoma.
Blood 1999;94(9):3262-4.
1999: Stilgenbauer S; Bullinger L; Benner A; Wildenberger K; Bentz M; Döhner K; Ho A D; Lichter P; Döhner H
Incidence and clinical significance of 6q deletions in B cell chronic lymphocytic leukemia.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1999;13(9):1331-4.
1999: Schaffner C; Stilgenbauer S; Rappold G A; Döhner H; Lichter P
Somatic ATM mutations indicate a pathogenic role of ATM in B-cell chronic lymphocytic leukemia.
Blood 1999;94(2):748-53.
1999: Bentz M; Stilgenbauer S; Lichter P; Döhner H
Interphase FISH in chronic lymphoproliferative disorders and comparative genomic hybridisation in the study of lymphomas.
Haematologica 1999;84 Suppl EHA-4():102-6.
1999: Döhner H; Stilgenbauer S; Döhner K; Bentz M; Lichter P
Chromosome aberrations in B-cell chronic lymphocytic leukemia: reassessment based on molecular cytogenetic analysis.
Journal of molecular medicine (Berlin, Germany) 1999;77(2):266-81.
1998: Barth T F; Döhner H; Werner C A; Stilgenbauer S; Schlotter M; Pawlita M; Lichter P; Möller P; Bentz M
Characteristic pattern of chromosomal gains and losses in primary large B-cell lymphomas of the gastrointestinal tract.
Blood 1998;91(11):4321-30.
1998: Stilgenbauer S; Nickolenko J; Wilhelm J; Wolf S; Weitz S; Döhner K; Boehm T; Döhner H; Lichter P
Expressed sequences as candidates for a novel tumor suppressor gene at band 13q14 in B-cell chronic lymphocytic leukemia and mantle cell lymphoma.
Oncogene 1998;16(14):1891-7.
1998: Stilgenbauer S; Döhner K; Bentz M; Lichter P; Döhner H
Molecular cytogenetic analysis of B-cell chronic lymphocytic leukemia.
Annals of hematology 1998;76(3-4):101-10.
1998: Bentz M; Plesch A; Stilgenbauer S; Döhner H; Lichter P
Minimal sizes of deletions detected by comparative genomic hybridization.
Genes, chromosomes & cancer 1998;21(2):172-5.
1998: Werner C A; Döhner H; Barth T F; Stilgenbauer S; Plesch A; Lichter P; Bentz M
Molecular cytogenetic analysis of low-grade B-cell neoplasias: a comparative genomic hybridization study.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 1998;144():53-60.
1997: Solinas-Toldo S; Lampel S; Stilgenbauer S; Nickolenko J; Benner A; Döhner H; Cremer T; Lichter P
Matrix-based comparative genomic hybridization: biochips to screen for genomic imbalances.
Genes, chromosomes & cancer 1997;20(4):399-407.
1997: Dreyling M H; Bullinger L; Ott G; Stilgenbauer S; Müller-Hermelink H K; Bentz M; Hiddemann W; Döhner H
Alterations of the cyclin D1/p16-pRB pathway in mantle cell lymphoma.
Cancer research 1997;57(20):4608-14.
1997: Stilgenbauer S; Schaffner C; Litterst A; Liebisch P; Gilad S; Bar-Shira A; James M R; Lichter P; Döhner H
Biallelic mutations in the ATM gene in T-prolymphocytic leukemia.
Nature medicine 1997;3(10):1155-9.
1997: Döhner H; Stilgenbauer S; Fischer K; Bentz M; Lichter P
Cytogenetic and molecular cytogenetic analysis of B cell chronic lymphocytic leukemia: specific chromosome aberrations identify prognostic subgroups of patients and point to loci of candidate genes.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1997;11 Suppl 2():S19-24.
1997: Döhner H; Stilgenbauer S; James M R; Benner A; Weilguni T; Bentz M; Fischer K; Hunstein W; Lichter P
11q deletions identify a new subset of B-cell chronic lymphocytic leukemia characterized by extensive nodal involvement and inferior prognosis.
Blood 1997;89(7):2516-22.
1997: Fischer K; Fröhling S; Scherer S W; McAllister Brown J; Scholl C; Stilgenbauer S; Tsui L C; Lichter P; Döhner H
Molecular cytogenetic delineation of deletions and translocations involving chromosome band 7q22 in myeloid leukemias.
Blood 1997;89(6):2036-41.
1996: Fischer K; Scholl C; Sàlat J; Fröhling S; Schlenk R; Bentz M; Stilgenbauer S; Lichter P; Döhner H
Design and validation of DNA probe sets for a comprehensive interphase cytogenetic analysis of acute myeloid leukemia.
Blood 1996;88(10):3962-71.
1996: Stilgenbauer S; Liebisch P; James M R; Schröder M; Schlegelberger B; Fischer K; Bentz M; Lichter P; Döhner H
Molecular cytogenetic delineation of a novel critical genomic region in chromosome bands 11q22.3-923.1 in lymphoproliferative disorders.
Proceedings of the National Academy of Sciences of the United States of America 1996;93(21):11837-41.
1996: Lichter P; Fischer K; Joos S; Fink T; Baudis M; Potkul R K; Ohl S; Solinas-Toldo S; Weber R; Stilgenbauer S; Bentz M; Döhner H
Efficacy of current molecular cytogenetic protocols for the diagnosis of chromosome aberrations in tumor specimens.
Cytokines and molecular therapy 1996;2(3):163-9.
1996: Bentz M; Werner C A; Döhner H; Joos S; Barth T F; Siebert R; Schröder M; Stilgenbauer S; Fischer K; Möller P; Lichter P
High incidence of chromosomal imbalances and gene amplifications in the classical follicular variant of follicle center lymphoma.
Blood 1996;88(4):1437-44.
1995: Döhner H; Stilgenbauer S; Fischer K; Schröder M; Bentz M; Lichter P
Diagnosis and monitoring of chromosome aberrations in hematological malignancies by fluorescence in situ hybridization.
Stem cells (Dayton, Ohio) 1995;13 Suppl 3():76-82.
1995: Schröder M; Mathieu U; Dreyling M H; Bohlander S K; Hagemeijer A; Beverloo B H; Olopade O I; Stilgenbauer S; Fischer K; Bentz M
CDKN2 gene deletion is not found in chronic lymphoid leukaemias of B- and T-cell origin but is frequent in acute lymphoblastic leukaemia.
British journal of haematology 1995;91(4):865-70.
1995: Stilgenbauer S; Leupolt E; Ohl S; Weiss G; Schröder M; Fischer K; Bentz M; Lichter P; Döhner H
Heterogeneity of deletions involving RB-1 and the D13S25 locus in B-cell chronic lymphocytic leukemia revealed by fluorescence in situ hybridization.
Cancer research 1995;55(16):3475-7.
1995: Döhner H; Fischer K; Bentz M; Hansen K; Benner A; Cabot G; Diehl D; Schlenk R; Coy J; Stilgenbauer S
p53 gene deletion predicts for poor survival and non-response to therapy with purine analogs in chronic B-cell leukemias.
Blood 1995;85(6):1580-9.
1994: Döhner H; Pilz T; Fischer K; Cabot G; Diehl D; Fink T; Stilgenbauer S; Bentz M; Lichter P
Molecular cytogenetic analysis of RB-1 deletions in chronic B-cell leukemias.
Leukemia & lymphoma 1994;16(1-2):97-103.
1993: Bentz M; Schröder M; Herz M; Stilgenbauer S; Lichter P; Döhner H
Detection of trisomy 8 on blood smears using fluorescence in situ hybridization.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1993;7(5):752-7.
1993: Stilgenbauer S; Döhner H; Bulgay-Mörschel M; Weitz S; Bentz M; Lichter P
High frequency of monoallelic retinoblastoma gene deletion in B-cell chronic lymphoid leukemia shown by interphase cytogenetics.
Blood 1993;81(8):2118-24.
1993: Döhner H; Pohl S; Bulgay-Mörschel M; Stilgenbauer S; Bentz M; Lichter P
Trisomy 12 in chronic lymphoid leukemias--a metaphase and interphase cytogenetic analysis.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1993;7(4):516-20.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Stephan Stilgenbauer

Research Profile (preview)

Disorders

Procedures

Anatomy

Chemicals & Drugs

Physiology

Living Beings

Concepts & Ideas

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Stephan Stilgenbauer (preview)

All Publications